2021 Drexel University Commencement Ceremonies College of Medicine

Total Page:16

File Type:pdf, Size:1020Kb

2021 Drexel University Commencement Ceremonies College of Medicine 2021 Drexel University Commencement Ceremonies College of Medicine MAY THE EIGHTEENTH PHILADELPHIA, PENNSYLVANIA MESSAGE FROM2021 THE PRESIDENT Dear Graduates, I am privileged to honor you for the outstanding achievement that brought you to this pivotal stage in your medical training, research and scientific studies. This is a moment of celebration, when you should take great pride in your many accomplishments. As you move on to further training, TABLE of CONTENTS career development and other professional experiences, you can be certain that your achievements are magnified many times Message from the President 1 over — because they are part of something much larger. It is that cherished legacy of helping patients, saving lives, Commencement Ceremony 2 advancing knowledge and expanding access to health care that is central to the mission of Drexel’s College of Medicine. Graduate Student Oath and The Physician’s Pledge 3 There are many challenges in your chosen fields, from the transformative power of technology, to the need for Citation of Fifty-Year Graduates patient-centered care, to the imperative to foster better 1971-2021 4 public health and ensure social justice. With the COVID-19 pandemic, your skills have never been more in demand Honorary Degree Recipient and the challenges before you loom that much larger. Even and Commencement Speaker 5 so, I am confident that you are joining the ranks of Drexel physicians, scientists and professionals who are making a Degree Recipients 6 difference across health care and related fields. I salute your efforts, and those of everyone who helped you Academic Awards 18 achieve this milestone. With the mentoring of the Drexel faculty and the support of your family and friends, you have Special Recognitions 20 completed a monumental learning journey. The Commencement Tradition 21 As you join a Drexel alumni community that spans the globe, it is my hope that your time at the College of Medicine Trustees of Drexel University 22 has instilled a desire to stay involved. The colleagues and friends from your time at Drexel will continue to enrich your life, and I urge you to serve as proud alumni ambassadors for the College you helped to shape and sustain. What a rare privilege you have in serving others with dedication as clinicians, researchers or administrators. You can be confident that your preparation has been outstanding and that your future is bright. On behalf of the trustees, faculty and professional staff of Drexel University, I wish you all the best in fulfilling your career and personal goals. Sincerely, John Fry President As a courtesy to our graduates and guests, please silence all phones and electronic devices during the Commencement Ceremony. 1 2021COMMENCEMENT CEREMONY Academic Procession Recognition of Student Awards Pomp and Circumstance March No 1 Charles B Cairns Edward Elgar Spoken Word Poem National Anthem “A Survivor’s Guide to Graduating” Star-Spangled Banner Theophilus Owofu Abah Francis Scott Key Class of 2021 Opening Remarks Charge to the Graduates Donna M Russo, PhD Charles B Cairns William Maul Measey Chair in Medical Education Interim Vice Dean for Educational Affairs Conferring of Graduate Degrees Senior Associate Dean for Curriculum Professor, Microbiology & Immunology John Fry Remarks by the Dean Elisabeth J Van Bockstaele, PhD Founding Dean, Graduate School of Biomedical Sciences Charles B Cairns, MD and Professional Studies Walter H. and Leonore Annenberg Dean, Chief Strategy Officer College of Medicine Senior Vice President for Graduate and Online Education Senior Vice President of Medical Affairs Dean, Graduate College Professor of Emergency Medicine Professor of Pharmacology and Physiology Jed Shumsky, PhD Welcome Senior Associate Dean of Educational John Fry and Academic Affairs President, Drexel University Professor of Neurobiology and Anatomy Greetings Investiture Stanley W Silverman Vice Chair, Drexel University Board of Trustees Administration of the Graduate Student Oath Elisabeth J Van Bockstaele Recognition of Academic Awards Conferring of Doctor of Medicine Degrees Charles B Cairns John Fry Citation of Fifty-Year Graduates 1971-2021 Charles B Cairns Charles B Cairns Donna M Russo Conferring of Honorary Degree Amy C Fuchs, MD Senior Associate Dean for Student Affairs John Fry Associate Professor of Medicine Charles B Cairns Seema Baranwal, MD Associate Dean for Student Affairs Doctor of Science Associate Professor of Medicine Drew Weissman, MD, PhD Linda Berardi-Demo, EdD Associate Dean, Admissions, Commencement Address Enrollment & Student Affairs Assistant Professor, Department of Medicine Drew Weissman All degrees awarded at this Commencement carry an official conferral date of May 14, 2021 2 DREXEL UNIVERSITY COLLEGE OF MEDICINE TUESDAY, MAY 182021 · PHILADELPHIA Investiture Farewell Amy C Fuchs Administration of the Physician’s Pledge Recessional Leon McCrea II, MD, MPH Senior Associate Dean of Diversity, Equity and Inclusion Associate Professor of Family, Community, & Faculty Marshals Preventive Medicine Amy Baranoski, MD ’03, MSc Assistant Dean, Phase One Curriculum Military Oath for MD Officers Associate Professor of Medicine Richard J Hamilton, MD, HU ’87 Dana C Farabaugh, MD ’03 Captain, Medical Corps, United States Navy (Retired) Associate Dean for Clinical Education Regional Associate Dean for Crozer Keystone Associate Professor of Obstetrics & Gynecology Health System Academic Chair and Professor of Emergency Medicine Nathalie S May, MD Associate Professor of Medicine Induction into the Alumni Association Anh-Thu Vu, MD Assistant Professor of Neurology Edward Siegel, MD ’12, MBA President-Elect, Alumni Association Graduate Remarks Sitara Soundararajan, MD Class of 2021 Graduate Student Oath World Medical Association Declaration of Geneva I will represent my profession The Physician’s Pledge: I WILL PRACTICE my profession honorably by conducting myself AS A MEMBER OF THE with conscience and dignity and and my professional endeavors in MEDICAL PROFESSION in accordance with good medical practice; a manner that is above reproach I I SOLEMNLY PLEDGE to dedicate pledge never to allow financial gain or my life to the service of humanity; I WILL FOSTER the honor and noble traditions of the medical ambition to cloud my judgment I will THE HEALTH AND WELL-BEING profession; pursue truth and create knowledge OF MY PATIENT will be my first for the greater good, but never to the consideration; I WILL GIVE to my teachers, colleagues, and students the respect detriment of others I will maintain I WILL RESPECT the autonomy and gratitude that is their due; scientific integrity in all my work and dignity of my patient; I WILL SHARE my medical I WILL MAINTAIN the utmost I will acknowledge and honor the knowledge for the benefit of the respect for human life; contributions of those who have patient and the advancement of preceded me and will commit myself I WILL NOT PERMIT healthcare; considerations of age, disease or to lifelong learning I will show I WILL ATTEND TO my own disability, creed, ethnic origin, compassion, embrace diversity and health, well-being, and abilities in gender, nationality, political order to provide care of the highest uphold excellence so that I become affiliation, race, sexual orientation, standard; a worthy role model deserving of social standing or any other factor to respect by all intervene between my duty and my I WILL NOT USE my medical patient; knowledge to violate human rights and civil liberties, even under threat; I WILL RESPECT the secrets that are confided in me, even after the I MAKE THESE PROMISES patient has died; solemnly, freely, and upon my honor ©2017 World Medical Association 3 Hahnemann Medical College Class of 1970 2021COMMENCEMENT CEREMONY Citation of College of Medicine Fifty-Year Graduates, 1971-2021 Hahnemann Medical College Stanley R Goldman, MD Carol E Ott, MD Suzanne Smith Godec, MD Class of 1971 Herbert P Goodheart, MD William Thomas Poirier, MD Norma Ruth Green, MD Leland Russell Abbey, MD James A Gosper, MD Melvyn P Richter, MD Martha Margaret Grout, MD Edward B Arenson Jr , MD Michael E Gotthelf, MD Michael V Rock, MD Dillie Grunauer, MD * Stephen Babic, MD Barry Edward Graham, MD Lawrence N Rossi, MD Mary Ann Haflin, Stephen E Barron, MD Lowell T Greenwald, MD * Millard A Ruddell, MD Nancy Jermanovich * Ollice Bates Jr , MD Gloria A Grzybicki, MD * Vadim M Schaldenko, MD Lorraine C King, MD Joseph M Becker, MD Robert H Hale, MD John C Schantz, MD Lyn C Lederman, MD Joseph M Bednarek, MD Ward D Heinrich Jr , MD Fredric H Schiffer, MD Kathleen R Malaney, MD Mark Berger, MD * Robert P Hershkowitz, MD * James G Shames, MD Kathleen Maloney, MD Georgetta C Bidwell-Voit, MD Lee H Hertz, MD Harlan J Sicherman, MD Claire Coverdale Marsh, MD Robert E Black, MD Orie E Kaltenbaugh, MD Ronald D Snyder, MD Margaret Honora McAloon, MD Michael H Bleshman, MD Sheldon R Karasick, MD Alan R Soltys, MD Marian McNamara, MD Harry L Bremer, MD George L Kirkpatrick, MD * Calvin R Stafford Jr , MD Jeanne Shamai Meisler, MD Eric N Burkett, MD William J Knox III, MD John D Sten, MD * Kathleen Mirante, MD * Patricia A Camody-Johnston, Clark Kopycinski, MD * Melvin J Tonkon, MD * MD Denise Mary Mulvihill, MD Gary H Kramer, MD William M Trachtenberg, MD Anthony G Campo Jr , MD Carol A Munch, MD Margaret A Kraybill, MD John Tumola, MD Henry H Canton Jr , MD Marjorie E Newman, MD * Lawrence F Kron, MD Michael J Vergare, MD Richard J Carlson, MD Doris Jean Phillips, MD John R Kuhns, MD Dean R Wasserman, MD Paul T Cass,
Recommended publications
  • Nature.2021.06.12 [Sat, 12 Jun 2021]
    [Sat, 12 Jun 2021] This Week News in Focus Books & Arts Opinion Work Research | Next section | Main menu | Donation | Next section | Main menu | | Next section | Main menu | Previous section | This Week Embrace the WHO’s new naming system for coronavirus variants [09 June 2021] Editorial • The World Health Organization’s system should have come earlier. Now, media and policymakers need to get behind it. Google’s AI approach to microchips is welcome — but needs care [09 June 2021] Editorial • Artificial intelligence can help the electronics industry to speed up chip design. But the gains must be shared equitably. The replication crisis won’t be solved with broad brushstrokes [08 June 2021] World View • A cookie-cutter strategy to reform science will cause resentment, not improvement. A light touch changes the strength of a single atomic bond [07 June 2021] Research Highlight • A technique that uses an electric field to tighten the bond between two atoms can allow a game of atomic pick-up-sticks. How fit can you get? These blood proteins hold a clue [04 June 2021] Research Highlight • Scientists pinpoint almost 150 biomarkers linked to intrinsic cardiovascular fitness, and 100 linked to fitness gained from training. Complex, lab-made ‘cells’ react to change like the real thing [02 June 2021] Research Highlight • Synthetic structures that grow artificial ‘organelles’ could provide insights into the operation of living cells. Elephants’ trunks are mighty suction machines [01 June 2021] Research Highlight • The pachyderms can nab a treat lying nearly 5 centimetres away through sheer sucking power. More than one-third of heat deaths blamed on climate change [04 June 2021] Research Highlight • Warming resulting from human activities accounts for a high percentage of heat-related deaths, especially in southern Asia and South America.
    [Show full text]
  • New York Society for Gastrointestinal Endoscopy the Spring Course
    New York Society for Gastrointestinal Endoscopy The Spring Course: Best of DDW 2021 Saturday, June 5, 2021 8:00 am – 3:15 pm Virtual Event The Spring Course: Best of DDW 2021 is jointly provided by the Albert Einstein College of Medicine – Montefiore Medical Center and the New York Society for Gastrointestinal Endoscopy Page 1 of 10 Course Description The Spring Course is devoted to a review of the most compelling topics discussed during Digestive Disease Week® 2021. Faculty will present critically important information on new drugs, the etiology and pathophysiology of disease states, the epidemiology of diseases, the medical, surgical and endoscopic treatment of disease, and the social impact of disease states pertaining to gastroenterology, endoscopy, and liver disease. The program includes a video forum of new endoscopic techniques as well as a summary of the major topics presented at the most important academic forum in gastroenterology, making for an invaluable educational experience for those who were unable to attend Digestive Disease Week® and an excellent summary review for all others. Learning Objectives • Discuss the spectrum of gastrointestinal diseases such as motility disorders and colorectal cancer and outline the enhancement and effectiveness of related treatment options such as the use of artificial intelligence in the detection and resection of polyps during colonoscopy • Evaluate advances in the methods of assessing disease status in patients with inflammatory bowel disease and discuss the application of these techniques
    [Show full text]
  • NYSNA Pension Plan New Participant Information • (877) RN BENEFITS [762-3633] • Rnbenefits.Org
    NYSNA Pension Plan New Participant Information • (877) RN BENEFITS [762-3633] • rnbenefits.org Defined benefit plan • Once a participant has completed five years of credited service, that participant will be VESTED and upon retirement will receive a monthly pension benefit for the rest of his/her life. Employer makes all contributions • RN contributes nothing Portable between more than 30 participating facilities in the New York City area (see back) How the pension benefit is calculated • Mathematical formula that recognizes earnings (base salary and experience differential only) and years of credited service • Based on the highest final average earnings for any five complete calendar years during the last 10 years of covered employment immediately before termination 3 retirement options to choose from For more detailed information on these options, please refer to your Welcome to the Pension Plan folder Normal retirement starting at age 65 Early retirement (unreduced) Must retire from active covered employment between the ages of 60 and 64 and have at least 20 years of credited service Early retirement Must retire between the ages of 55 and 64 (reduced by 1/2% for each month that early retirement precedes normal retirement at age 65) The information contained herein should not be viewed as a substitute for the Plan document, the most recent Summary Plan Description, and any relevant Summary of Material Modifications. In case of discrepancies or contradictions, the language and terms of the Plan document, the SPD, and SMMs shall prevail. 9/2020 Deferred Vested Benefit • Available to participants who are vested and leave the Plan prior to being eligible for retirement reductions • Payable at Normal Retirement age 65 with no reductions or between age 55 and 64 with early retirement reductions The Preretirement Survivor Benefit • If a vested participant dies before she/he retires • If married, the spouse is automatically the beneficiary.
    [Show full text]
  • Fall 2016 Is Available in the Laboratory of Dr
    RNA Society Newsletter Aug 2016 From the Desk of the President, Sarah Woodson Greetings to all! I always enjoy attending the annual meetings of the RNA Society, but this year’s meeting in Kyoto was a standout in my opinion. This marked the second time that the RNA meeting has been held in Kyoto as a joint meeting with the RNA Society of Japan. (The first time was in 2011). Particular thanks go to the local organizers Mikiko Siomi and Tom Suzuki who took care of many logistical details, and to all of the organizers, Mikiko, Tom, Utz Fischer, Wendy Gilbert, David Lilley and Erik Sontheimer, for putting together a truly exciting and stimulating scientific program. Of course, the real excitement in the annual RNA meetings comes from all of you who give the talks and present the posters. I always enjoy meeting old friends and colleagues, but the many new participants in this year’s meeting particularly encouraged me. (Continued on p2) In this issue : Desk of the President, Sarah Woodson 1 Highlights of RNA 2016 : Kyoto Japan 4 Annual Society Award Winners 4 Jr Scientist activities 9 Mentor Mentee Lunch 10 New initiatives 12 Desk of our CEO, James McSwiggen 15 New Volunteer Opportunities 16 Chair, Meetings Committee, Benoit Chabot 17 Desk of the Membership Chair, Kristian Baker 18 Thank you Volunteers! 20 Meeting Reports: RNA Sponsored Meetings 22 Upcoming Meetings of Interest 27 Employment 31 1 Although the graceful city of Kyoto and its cultural months. First, in May 2016, the RNA journal treasures beckoned from just beyond the convention instituted a uniform price for manuscript publication hall, the meeting itself held more than enough (see p 12) that simplifies the calculation of author excitement to keep ones attention! Both the quality fees and facilitates the use of color figures to and the “polish” of the scientific presentations were convey scientific information.
    [Show full text]
  • MD Class of 2021 Commencement Program
    Commencement2021 Sunday, the Second of May Two Thousand Twenty-One Mount Airy Casino Resort Mt. Pocono, Pennsylvania Geisinger Commonwealth School of Medicine celebrates the conferring of Doctor of Medicine degrees For the live-stream event recording and other commencement information, visit geisinger.edu/commencement. Commencement 2021 1 A message from the president and dean Today we confer Doctor of Medicine degrees upon our our past, but we are not afraid to evolve and embrace ninth class. Every year at commencement, I like to reflect innovation, change and our future. To me, this courage, on the ways in which each class is unique. The Class resilience and creative thinking have come to be of 2021 presents an interesting duality. It is the first of synonymous with a Geisinger Commonwealth School some things and also the last of many. Like the Roman of Medicine diploma — and I have received enough god Janus, this class is one that looks back on our past, feedback from fellow physicians, residency program but also forward to the future we envision for Geisinger directors and community members to know others Commonwealth School of Medicine. believe this, too. Every student who crosses the stage Janus was the god of doors and gates, of transitions today, through considerable personal effort, has earned and of beginnings and ends. It is an apt metaphor, the right to claim the privileges inherent in because in so many ways yours has been a transitional that diploma. class. You are the last class to be photographed on Best wishes, Class of 2021. I know that the experiences, the day of your White Coat Ceremony wearing jackets growth and knowledge bound up in your piece of emblazoned “TCMC.” You are also, however, the first parchment will serve you well and make us proud in the class offered the opportunity of admittance to the Abigail years to come.
    [Show full text]
  • COVID-19 Vaccination in Patients with Liver Disease
    COVID-19 Vaccination in Patients with Liver Disease Moderated By: Kyong-Mi Chang, MD, FAASLD & Gregory A. Poland, MD © 2020 AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES WWW.AASLD.ORG Webinar Moderator Kyong-Mi Chang, MD, FAASLD • Professor of Medicine (GI) – University of Pennsylvania Perelman School of Medicine • Associate Chief of Staff and Associate Dean for Research at the affiliated Corporal Michael J. Crescenz VA Medical Center in Philadelphia © 2020 AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES WWW.AASLD.ORG 2 Webinar Moderator Gregory A. Poland, MD • Mary Lowell Leary Professor of Medicine at the Mayo Clinic in Rochester, Minnesota • Director of the Mayo Clinic's Vaccine Research Group © 2020 AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES WWW.AASLD.ORG 3 Webinar Agenda Talks Speakers Webinar and Presenter Introductions Dr. Chang & Poland "Safety and efficacy of conventional vaccination in patients with liver Dr. Hugo Rosen disease” “Safety of vaccines with adenoviral vectors in liver disease patients” Prof. Eleanor Barnes “Safety of RNA vaccines in liver disease patients” - Moderna Dr. Drew Weissman “Safety of RNA vaccines in liver disease patients” - Pfizer Dr. Onyema Ogbuagu Panel Discussion / Q&A All © 2020 AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES WWW.AASLD.ORG 4 Webinar Q&A • Submit your questions anytime during the webinar in the Q&A box at the top or bottom of your screen. • Questions will be answered at the end of the presentations. © 2020 AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES WWW.AASLD.ORG 5 Webinar Presenter Hugo R. Rosen, MD, FAASLD • Professor and Chair, Department of Medicine • Kenneth T.
    [Show full text]
  • HMO Proactive Tiered Network Hospital List
    Save with Keystone HMO Proactive, our most popular plans Keystone HMO Proactive health plans are our most popular for good reason: You get access to high-quality care and save money. Not only do you pay less for your monthly premiums, but you can save even more by choosing doctors and hospitals in Tier 1 – Preferred. Save with Tier 1 – Preferred Tier 1 – Preferred includes more than 50 percent of the network. Keystone HMO Proactive offers the same essential health benefits as our other health plans, including doctor visits, Tier 1 – Preferred hospital stays, prescription drug coverage, blood tests, and X-rays. The difference is its tiered provider network, which gives you the option to pay less for care by choosing Tier 1 –Preferred providers. Here are the most important things to know about Keystone HMO Proactive: • You can visit any doctor or hospital in the Independence Blue Cross network once you have a referral. Tier 2 – Enhanced Tier 3 – Standard • You will select a PCP to coordinate your care and refer you to specialists. • Some services cost the same no matter what provider you Save even more choose — like preventive care, emergency room visits, and Keystone HMO Silver Proactive Select and Keystone HMO Silver urgent care. Proactive Value: These lower-premium options are only available • When you use doctors and hospitals in Tier 1 – Preferred, when you purchase directly from Independence Blue Cross. you pay the lowest out-of-pocket costs. Keystone HMO Silver Proactive Value includes a deductible for • The choice is always yours. You can choose Tier 1 providers Tiers 1 – 3 for some services.
    [Show full text]
  • What If We Could Make RNA Accessible to Everyone?
    What if we could make RNA accessible to everyone? Investor Presentation | © 2021 GreenLight Biosciences. All rights reserved. GreenLight confidential. 1 Disclaimer Caution Regarding Forward Looking Statements Certain statements included in this Investor Presentation (“Presentation”) that are not historical facts are forward-looking statements for purposes of US law. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “pipeline”, “predict,” “project,” “forecast,” “potential,” “seem,” “seek,” “strategy,” “future,” “outlook,” “opportunity,” “should,” “would,” “will be,” “will continue,” “will likely result” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding operating results, product field tests, clinical trials, future liquidity, the proposed transaction between Environmental Impact Acquisition Corporation ("ENVI") and GreenLight, including statements as to the expected timing, funding, completion and effects of the Proposed Business Combination or other steps or transactions associated with it and financial estimates, forecasts, and performance metrics and projections of market opportunity. These statements are based on various assumptions, whether or not identified in this Presentation, and on the current expectations of the respective management of GreenLight and Environmental Impact Acquisition Corporation ("ENVI") and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by an investor as, a guarantee, an assurance, a prediction, or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions.
    [Show full text]
  • Newsletter VOL
    The Obstetrical Society of Philadelphia To embrace our legacy, foster collegiality, and share expertise to improve the health of women in Philadelphia and beyond OCTOBER 2018 Newsletter VOL . 46, NO. 2 President’s Message Upcoming Lecture The Obstetrical Society of Philadelphia; Is It Worth Our Time and Effort? PETER F. SCHNATZ, D.O. As we celebrate our sesquicentennial anniversary and spend time focusing on our accomplishments and achievements over the years, it causes us to Thursday, November 15, 2018, 6:00 PM look forward to the future of our organization. Many state OBGYN societies have stopped functioning over the past decade or so, for a variety of reasons, including fi nances, time constraints, the busyness of our personal and professional lives, and “Osteoporosis: an assortment of other competing factors. Before strategizing ways to be successful Update and Overview” this year, and in the coming years, it is important to ask the following question; “Is the society truly of value or are we simply keeping it going for the sake of nostalgia?” We hope that you will be able to join us While the acquisition of medical knowledge and guest presenters are at the core of for our October meeting, when Michael what we do, this can be acquired through a variety of mechanisms and in and of itself McClung, M.D., of Oregon Osteoporosis Center will discuss osteoporosis. is probably not worth sustaining the organization. As I assess our society, here are some of the core values and reasons I see to spend our time, fi nances, and resources in See page 3 for details.
    [Show full text]
  • List Internal Medicine Residency Training Programs Participating in the Icompare Trial and Trial Group Assignment Program Name
    List Internal Medicine Residency Training Programs Participating in the iCOMPARE Trial and Trial Group Assignment1 Program Name Intervention Abington Memorial Hospital Program Control Advocate Lutheran General Hospital Program Control Atlantic Health (Morristown) Program Control Banner Good Samaritan Medical Center Program Experimental Baylor College of Medicine Program Control Baystate Medical Center/Tufts University School of Medicine Program Experimental Beth Israel Deaconess Medical Center Program Control Brigham and Women's Hospital Program Control Brown University Program Control Canton Medical Education Foundation/NEOMED Program Control Carilion Clinic-Virginia Tech Carilion School of Medicine Program Experimental Case Western Reserve University (MetroHealth) Program Experimental Case Western Reserve University/University Hospitals Case Medical Experimental Center Program Cedars-Sinai Medical Center Program Control Cleveland Clinic Foundation Program Experimental Creighton University Program Experimental Drexel University College of Medicine/Hahnemann University Hospital Control Program Duke University Hospital Program Experimental Eastern Virginia Medical School Program Experimental Emory University Program Experimental Geisinger Health System Program Experimental George Washington University Program Experimental Georgetown University Hospital/Washington Hospital Center Program Control Greater Baltimore Medical Center Program Control Henry Ford Hospital/Wayne State University Program Experimental Jackson Memorial Hospital/Jackson
    [Show full text]
  • Allergy/Immunology Long Island Jewish Medical Center Thomas
    Einstein Medical Center Internal Medicine Residency Fellowship Appointments 1999-present (Updated 12-12-2019, some advanced fellowships included) Allergy/Immunology Long Island Jewish Medical Center Thomas Jefferson University University of Pennsylvania Cardiology Einstein Medical Center (29) Allegheny General Hospital Baylor College of Medicine (5) Baystate Medical Center Cedars Sinai Medical Center Cleveland Clinic, Florida Creighton University Danbury Hospital Drexel University/ Hahnemann Hospital Emory University (8) Geisinger Medical Center (3) Jersey Shore University Medical Center Lankenau Medical Center (2) Lehigh Valley Hospital (2) Loma Linda University Hospital (4) Michigan State University Ochsner Clinic Foundation St. Luke's Hospital, Bethlehem St Vincent’s Hospital, Worcester, MA Tufts Medical Center UMDNJ Robert Wood Johnson, Camden UMDNJ-SOM University of Arkansas University of Buffalo University of California at Davis University of Cincinnati University of Florida University of Illinois at Chicago (2) University of Kentucky University of Miami Jackson Memorial University of Minnesota University of Pittsburgh University of Texas, Galveston University of Texas, Houston (2) Virginia Commonwealth University Critical Care University of Pittsburgh Medical Center University of Tennessee Endocrinology Einstein Medical Center (3) Baylor College of Medicine (2) Case Western University Cedars Sinai Medical Center Cooper University Hospital Johns Hopkins University Mt Sinai Medical Center, NY St Luke’s Roosevelt Stony Brook University
    [Show full text]
  • The Pandemic Pipeline Companies Are Doing Their Best to Accelerate Experimental Drugs and Vaccines for COVID-19 Through the Pipeline
    news feature Credit: Plrang GFX / Alamy Stock Photo The pandemic pipeline Companies are doing their best to accelerate experimental drugs and vaccines for COVID-19 through the pipeline. Each faces its own set of challenges, but all agree on the need for a radical rethink of the clinical development process for pandemics. John Hodgson his week, Moderna Therapeutics’ of the mRNA vaccine could reach clinics as Approved small molecules are already in use modified mRNA vaccine for COVID- early as 2021. This will be too late for the off label as adjunct therapies for critically ill T19 began phase 1 clinical testing. current pandemic. And given that no mRNA patients (like Fujifilm Toyama Chemical’s From the first description of the novel vaccine has ever been approved, mRNA- favipiravir), with several other experimental coronavirus (SARS-CoV-2) genome on 10 1273 faces numerous challenges in clinical drugs (like Gilead’s remesdivir) under January, it took the company just 42 days development and manufacture before it has investigation. Repurposed monoclonal to produce the first batches of its vaccine the possibility of being made available for antibodies (mAbs) developed against (mRNA-1273), which encodes a prefusion- global immunization. previous coronaviruses, such as severe stabilized form of the SARS-CoV-2 spike (S) In the meantime, a host of other acute respiratory syndrome (SARS) virus protein. If it can successfully negotiate safety therapeutic modalities are being accelerated and Middle Eastern respiratory syndrome and efficacy testing on a larger scale, batches through discovery and development. (MERS) virus, promise passive immunity NATURE BIOTECHNOLOGY | VOL 38 | MAY 2020 | 523–532 | www.nature.com/naturebiotechnology 523 news feature College in London, agrees.
    [Show full text]